CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: BIO 2016 (619) Pharma Startups (4732)
Founded in 1989, La Jolla Pharmaceutical Company is a biotechnology company leading the development and marketing of novel therapeutics for antibody-mediated autoimmune diseases, such as lupus and antibody-mediated thrombosis.
Company (IPO / Went public)
Phone: 858-452-6600
4365 Executive Drive
Suite 300
San Diego, 92121
California, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| LaJolla Pharmaceutical Company | $290.6M | Feb 6, 2006 |
| OraPharma | $105.9M | Jun 18, 2012 |
| Bayhill Therapeutics | $97.4M | Jun 11, 2011 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Modified pectins, compositions and methods related thereto | May 06, 2013 | May 13, 2014 | Patent |
| Modified pectins, compositions and methods related thereto | May 06, 2013 | Feb 25, 2014 | Patent |
| Methods of treating iron overload | Sep 06, 2017 | Application | |
| Compositions and methods related to gentamicin | Jan 27, 2017 | Application | |
| Methods of administering hepcidin | Jan 06, 2017 | Application |
Download PDF